SCHEMBL6592289

SCHEMBL6592289

COc1ccc(CN2C(=O)N(Cc3ccc4ccccc4c3)CC2CCOS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MMP1 P03956 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ ADAM17 P78536 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ CASP3 P42574 2/20 0.39
▸ CASP7 P55210 2/20 0.39
▸ HCRTR1 O43613 3/20 0.38
▸ HCRTR2 O43614 3/20 0.38
▸ NPBWR1 P48145 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3987303 0.89 KCNA5 (0.40) LMNASMN1; SMN2ALDH1A1MAPTCASP3
SCHEMBL13792676 0.85 LMNA (0.43) LMNASMN1; SMN2MMP1MMP9MMP13
SCHEMBL3988359 0.85 LMNA (0.43) LMNASMN1; SMN2MMP1MMP9MMP13
SCHEMBL3990845 0.85 KCNA5 (0.42) LMNAHTTSMN1; SMN2ALDH1A1MAPT
SCHEMBL3991468 0.82 HCRTR1 (0.45) MMP13HCRTR1HCRTR2NPBWR1
SCHEMBL3996224 0.79 DRD2 (0.37) LMNAHTTSMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL26103002 0.74 GRM2 (0.51) LMNASMN1; SMN2MMP1MMP9MMP13
SCHEMBL3987812 0.72 LMNA (0.45) LMNASMN1; SMN2ALDH1A1MAPTCASP3
SCHEMBL3989499 0.72 PPARA (0.44) TDP1L3MBTL1ALDH1A1
SCHEMBL13792724 0.72 PPARA (0.44) TDP1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544812-B2 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus ELI LILLY AND COMPANY (US) 2009-06-09 — — US disclosed
US-7544812-B2 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus ELI LILLY AND COMPANY (US) 2009-06-09 — — US disclosed
EP-1453811-A2 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2004-09-08 — — EP disclosed
WO-2003048130-A2 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2003-06-12 — — WO disclosed
Send feedback